| Efficacy and Safety of Different Dosing Regimens of Rivaroxaban in Patients With Atrial Fibrillation for Stroke Prevention: A Systematic Review and Meta-Analysis. | 2024 | Cureus |
| Comparing the Clinical Outcomes Observed with Rivaroxaban Versus Warfarin for the Management of Obese Patients with Non valvular Atrial Fibrillation: A Systematic Review and Meta analysis. | 2024 | Cardiovascular Drugs and Therapy |
| Outcome of antithrombotic therapy in cancer patients with catheter-related thrombosis: A systematic review. | 2023 | Frontiers in Cardiovascular Medicine |
| Comparison of Different Chronic Maintenance Antithrombotic Strategies in Patients with Coronary Artery Disease: A Systematic Review and Network Meta-Analysis. | 2023 | Cardiovascular therapeutics |
| Comparative outcomes associated with rivaroxaban versus warfarin use in elderly patients with atrial fibrillation or acute venous thromboembolism managed in the United States: A systematic review of observational studies. | 2023 | Current Medical Research and Opinion |
| Efficacy and safety of rivaroxaban versus apixaban for venous thromboembolism: A systematic review and meta-analysis of observational studies. | 2023 | Journal of Thrombosis and Thrombolysis |
| Novel oral anticoagulants in patients with atrial fibrillation and moderate to severe mitral stenosis: A systematic review. | 2023 | Cureus |
| Application of rivaroxaban in patients with non-valvular atrial fibrillation and end-stage kidney disease: A systematic review and meta-analysis. | 2023 | Frontiers in Cardiovascular Medicine |
| Is a lower dose of rivaroxaban required for Asians? A systematic review of a population pharmacokinetics and pharmacodynamics analysis of rivaroxaban. | 2023 | Pharmaceutics |
| The association of nnon-vitamin K antagonist oral anticoagulants vs. warfarin and the risk of fractures for patients with atrial fibrillation: A systematic review and meta-analysis. | 2023 | Acta Cardiology |
| Efficacy and safety outcomes of long-term anti-thrombotic treatment of chronic coronary artery disease: A systematic review and network meta-analysis. | 2023 | Frontiers in Cardiovascular Medicine |
| Comparisons of effectiveness and safety between on-label dosing, off-label underdosing, and off-label overdosing in Asian and non-Asian atrial fibrillation patients treated with rivaroxaban: A systematic review and meta-analysis of observational studies. | 2023 | Europace |
| Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis. | 2023 | The Cochrane Database of Systematic Reviews |
| Safety of Direct Oral Anticoagulants for Gastrointestinal Hemorrhage in Patients With Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-analysis of Real-world Studies. | 2023 | Journal of Clinical Gastroentorology |
| Efficacy of 11 anticoagulants for the prevention of venous thromboembolism after total hip or knee arthroplasty: A systematic review and network meta-analysis. | 2023 | Medicine |
| Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Review of Economic Evaluations. | 2023 | Value in Health Regional Issues |
| Severe Bleeding Risk of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Stroke Prevention and Treatment in Patients with Atrial Fibrillation: A Systematic Review and Network Meta-Analysis. | 2023 | Cardiovascular Drugs and Therapy |
| Comparison of Aspirin and Rivaroxaban Plus Aspirin in the Management of Stable Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomized Controlled Trials. | 2022 | International Journal of General Medicine |
| Comparison of the Efficacy and Safety of Rivaroxaban and Enoxaparin as Thromboprophylaxis Agents for Orthopedic Surgery - Systematic Review and Meta-Analysis. | 2022 | Journal of Clinical Medicine |
| Oral anticoagulants and relative risk of acute kidney injury in patients with atrial fibrillation: A systematic review and network meta-analysis. | 2022 | American Heart Journal Plus: Cardiology Research and Practice |
| Outpatient versus inpatient treatment for acute pulmonary embolism. | 2022 | Cochrane Database of Systematic Reviews |
| Efficacy and safety of direct oral anticoagulants (DOACs) versus warfarin in atrial fibrillation patients with prior stroke: A systematic review and meta analysis. | 2022 | Cardiovascular Drugs and Therapy |
| Efficacy and safety of direct oral anticoagulants with and without aspirin: A systematic review and meta-analysis. | 2022 | IJC Heart & Vasculature |
| Latest outcomes of transcatheter left atrial appendage closure devices and direct oral anticoagulant therapy in patients with atrial fibrillation over the past 5 years: A systematic review and meta analysis. | 2022 | Cardiovascular Intervention and Therapeutics |
| Extended venous thromboprophylaxis in patients hospitalized for acute ischemic stroke: A systematic review and meta-analysis. | 2022 | European Journal of Internal Medicine |
| Wound complications and bleeding with new oral anticoagulants in patients undergoing total joint arthroplasty: A systematic review and meta-analysis of randomized controlled trials. | 2022 | British Journal of Pharmacology |
| Risk of intracranial hemorrhage with direct oral anticoagulants: A systematic review and meta-analysis of randomized controlled trials. | 2022 | Journal of Neurology |
| New oral anticoagulants for venous thromboembolism prophylaxis in total hip and knee arthroplasty: A systematic review and network meta-analysis. | 2022 | Frontiers in Pharmacology |
| Antithrombotic therapy for secondary prevention of unprovoked venous thromboembolism: A systematic review and network meta-analysis of randomized controlled trials. | 2022 | Annals of Medicine |
| Risk of Intracranial hemorrhage caused by direct oral anticoagulants for stroke prevention in patients with atrial fibrillation (from a network meta-analysis of randomized controlled trials). | 2022 | The American Journal of Cardiology |
| Meta-analysis comparing apixaban versus rivaroxaban for management of patients with nonvalvular atrial fibrillation. | 2022 | The American Journal of Cardiology |
| Standard vs. low dose rivaroxaban in patients with atrial fibrillation: A systematic review and meta analysis. | 2022 | European Journal of Clinical Pharmacology |
| Comparative efficacy and safety of oral anticoagulants for the treatment of venous thromboembolism in the patients with different renal functions: A systematic review, pairwise and network meta-analysis. | 2022 | BMJ Open |
| Direct oral anticoagulants for cancer-associated venous thromboembolisms: A systematic review and network meta-analysis. | 2022 | Internal Medicine Journal |
| Risk of stroke and bleeding in relation to hypertension in anticoagulated patients with atrial fibrillation: A meta-analysis of randomised controlled trials. | 2022 | Acta Cardiologica |
| Severe bleeding risks of direct oral anticoagulants in the prevention and treatment of venous thromboembolism: A network meta-analysis of randomised controlled trials. | 2022 | European Journal of Vascular and Endovascular Surgery |
| Combination anticoagulant or P2Y12 inhibitor with low-dose aspirin versus low-dose aspirin alone in patients at risk or with documented coronary and/or peripheral artery disease. | 2022 | Current Medical Research and Opinion |
| Real-world evidence comparing oral anticoagulants in non-valvular atrial fibrillation: A systematic review and network meta-analysis. | 2022 | Future Cardiology |
| Prevention of nnon-vitamin K oral anticoagulants-related gastrointestinal bleeding with acid suppressants: A systematic review and meta-analysis. | 2022 | Clinical and Applied Thrombosis/Hemostasis |
| Risk of stroke and bleeding in relation to hypertension in anticoagulated patients with atrial fibrillation: A meta-analysis of randomised controlled trials. | 2022 | Acta Cardiologica |
| Thromboprophylaxis after knee arthroscopy does not decrease the risk of deep vein thrombosis: A network meta-analysis. | 2022 | Knee Surgery, Sports Traumatology, Arthroscopy |
| Safety of direct oral anticoagulants in patients with liver disease: A systematic review and meta-analysis. | 2022 | International Journal of Clinical and Laboratory Medicine |
| Efficacy and safety of vitamin-k antagonists and direct oral anticoagulants for stroke prevention in patients with heart failure and sinus rhythm: An updated systematic review and meta-analysis of randomized clinical trials. | 2022 | International Journal of Stroke |
| Effectiveness and Safety of Nonvitamin K Oral Anticoagulants Rivaroxaban and Apixaban in Patients with Venous Thromboembolism: A Meta-Analysis of Real-World Studies. | 2022 | Cardiovascular Therapeutics |
| Comparing the Clinical Outcomes Observed with Rivaroxaban Versus Warfarin for the Management of Obese Patients with Non-valvular Atrial Fibrillation: A Systematic Review and Meta-analysis. | 2022 | Cardiovascular Drugs and Therapy |
| Direct oral anticoagulants for venous thromboembolism in cancer patients: A systematic review and network meta-analysis. | 2022 | Supportive Care in Cancer |
| Comparative efficacy and safety of antiplatelet or anticoagulant therapy in patients with chronic coronary syndromes after percutaneous coronary intervention: A network meta-analysis of randomized controlled trials. | 2022 | Frontiers in pharmacology |
| Efficacy and Safety of Direct Oral Anticoagulants in Stable Coronary Artery Disease and Atrial Fibrillation: A Systematic Review and Network Meta-Analysis. | 2022 | Clinical and Applied Thrombosis/Hemostasis |
| Risk of nonmajor bleeding upon use of direct oral anticoagulants for preventing and treating venous thromboembolism: A network meta-analysis. | 2022 | Vascular Medicine |
| Antithrombotic Therapy for Symptomatic Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis. | 2022 | Drugs |
| Efficacy and Safety of Rivaroxaban Compared with Other Therapies Used in Patients with Peripheral Artery Disease Undergoing Peripheral Revascularization: A Systematic Literature Review and Network Meta-Analysis. | 2021 | Cardiovascular Therapeutics |
| Efficacy of rivaroxaban in prevention of post-thrombotic syndrome: A systematic review and meta-analysis. | 2021 | Journal of Vascular Surgery: Venous and Lymphatic Disorders |
| Drug-drug interactions leading to adverse drug reactions with rivaroxaban: A systematic review of the literature and analysis of VigiBase. | 2021 | Journal of Personalized Medicine |
| Severe bleeding risk of direct oral anticoagulants versus vitamin K antagonists for stroke prevention and treatment in patients with atrial fibrillation: A systematic review and network meta-analysis. | 2021 | Cardiovascular Drugs and Therapy |
| Antiplatelet therapy with or without anticoagulant therapy for lower extremity peripheral artery disease: A systematic review. | 2021 | American Journal of Health-System Pharmacy |
| Comparison of non-vitamin K antagonist oral anticoagulants on bleeding and thrombosis. | 2021 | Journal of Clinical Pharmacy and Therapeutics |
| Twice- or once-daily dosing of direct oral anticoagulants, a systematic review and meta-analysis. | 2021 | Thrombosis Research |
| Association of risk of dementia with direct oral anticoagulants versus warfarin use in patients with non-valvular atrial fibrillation: A systematic review and meta-analysis. | 2021 | Journal of Cardiovascular Pharmacology |
| Non-vitamin K oral anticoagulants and risk of fractures: A systematic review and meta-analysis. | 2021 | EP Europace |
| A network meta-analysis of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and diabetes mellitus. | 2021 | Acta Cardiologica |
| Fracture risks in patients treated with different oral anticoagulants: A systematic review and meta-analysis. | 2021 | Journal of the American Heart Association |
| Efficacy and safety of anticoagulants for postoperative thrombophylaxis in total hip and knee arthroplasty: A PRISMA-compliant Bayesian network meta-analysis. | 2021 | PLoS One |
| Efficacy and safety of dual-pathway inhibition in patients with cardiovascular disease: a meta-analysis of 49 802 patients from 7 randomized trials. | 2021 | European Heart Journal |
| Ranking the efficacy of anticoagulants for the prevention of venous thromboembolism after total hip or knee arthroplasty: A systematic review and a network meta-analysis. | 2021 | Pharmacological Research |
| Benefits and harms of low-dose rivaroxaban in Asian patients with atrial fibrillation: A systematic review and meta-analysis of real-world studies. | 2021 | Frontiers in Pharmacology |
| Real-world persistence to direct oral anticoagulants in patients with atrial fibrillation: A systematic review and network meta-analysis. | 2021 | Current Medical Research and Opinion |
| The efficacy and safety of direct oral anticoagulants plus aspirin in symptomatic lower extremity peripheral arterial disease: A systematic review and meta‑analysis of randomized controlled trials. | 2021 | Journal of Thrombosis and Thrombolysis |
| Low dose rivaroxaban for atherosclerotic cardiovascular diseases: A systematic review and meta-analysis. | 2021 | Frontiers in Pharmacology |
| Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: A meta-analysis. | 2021 | Thrombosis Journal |
| Efficacy and safety of Xa inhibitors in patients with heart failure and coronary or peripheral artery disease: A systematic review and meta-analysis of randomized controlled trials. | 2021 | Annals of Palliative Medicine |
| The association of fracture risk in atrial fibrillation patients and long-term anticoagulant therapy category: A systematic review and meta-analysis. | 2021 | PeerJ |
| Reasons for discontinuing oral anticoagulation therapy for atrial fibrillation: A systematic review. | 2021 | Age and Ageing |
| Efficacy and safety of non-vitamin K antagonist oral anticoagulants in pediatric venous thromboembolism treatment and thromboprophylaxis: A systematic review of the literature. | 2021 | Seminars in Thrombosis and Hemostasis |
| Use of direct-acting oral anticoagulants in solid organ transplantation: A systematic review. | 2021 | Pharmacotherapy |
| Direct-acting oral anticoagulants versus warfarin in relation to risk of gastrointestinal bleeding: A systematic review and meta-analysis of randomized controlled trials. | 2021 | Annals of Gastroenterology |
| A systematic review of the efficacy and safety of direct oral anticoagulants in atrial fibrillation patients with diabetes using a risk index. | 2021 | Journal of Clinical Medicine |
| Bleeding outcomes after dental extraction in patients under direct-acting oral anticoagulants vs. vitamin K antagonists: A systematic review and meta-analysis. | 2021 | Frontiers in Pharmacology |
| Current trends in the duration of anticoagulant therapy for venous thromboembolism: A systematic review. | 2021 | Cureus |
| The efficacy and safety of rivaroxaban in coronary artery disease patients with heart failure and sinus rhythm: A systematic review and meta-analysis. | 2021 | European Journal of Clinical Pharmacology |
| Benefit and risk of adding rivaroxaban in patients with coronary artery disease: A systematic review and meta-analysis. | 2021 | Clinical Cardiology |
| Extended Thromboprophylaxis With Betrixaban or Rivaroxaban for Acutely Ill Hospitalized Medical Patients: Meta-Analysis of Prespecified Subgroups. | 2021 | Critical Pathways in Cardiology |
| Rivaroxaban for cancer-associated venous thromboembolism. | 2021 | Science Progress |
| A comparison of aspirin against rivaroxaban for venous thromboembolism prophylaxis after hip or knee arthroplasty: A meta-analysis. | 2020 | Journal of Orthopaedic Surgery |
| A systematic review of network meta-analyses and real-world evidence comparing apixaban and rivaroxaban in nonvalvular atrial fibrillation. | 2020 | Clinical and Applied Thrombosis/Hemostasis |
| The safety and efficacy of rivaroxaban compared with warfarin in patients with atrial fibrillation and diabetes: A systematic review and meta-analysis. | 2020 | American Journal of Cardiovascular Drugs |
| Risk of post-thrombotic syndrome after deep vein thrombosis treated with rivaroxaban versus vitamin-K antagonists: A systematic review and meta-analysis. | 2020 | Thrombosis Research |
| Clinical effectiveness and safety of aspirin for venous thromboembolism prophylaxis after total hip and knee replacement. | 2020 | JAMA |
| Efficacy and safety of low dose rivaroxaban in patients with coronary heart disease: A systematic review and meta-analysis. | 2020 | Journal of Thrombosis and Thrombolysis |
| Efficacy and safety of non-vitamin K anticoagulants for atrial fibrillation in relation to different renal function levels: A network meta-analysis. | 2020 | Cardiovascular Therapeutics |
| Risk of major gastrointestinal bleeding with new vs conventional oral anticoagulants: A systematic review and meta-analysis. | 2020 | Clinical Gastroenterology and Hepatology |
| Real-world adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation. | 2020 | Circulation: Cardiovascular Quality and Outcomes |
| Efficacy and safety of direct oral anticoagulants in elderly patients with atrial fibrillation: A network meta-analysis. | 2020 | Frontiers in Medicine |
| Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy. | 2020 | Cochrane Database of Systematic Reviews |
| Efficacy of rivaroxaban for pulmonary embolism | 2019 | Medicine |
| Effectiveness and safety of rivaroxaban for the prevention of thrombosis following total hip or knee replacement: A systematic review and meta-analysis. | 2019 | Medicine |
| Systematic review and meta-analysis of the efficacy and safety of apixaban compared to rivaroxaban in acute VTE in the real world. | 2019 | Blood Advances |
| Rivaroxaban versus aspirin in prevention of venous thromboembolism: A meta-analysis of 9 randomized controlled trials comprising 7,656 patients. | 2019 | Stroke, Systemic or Venous Thromboembolism |
| A systematic review of direct oral anticoagulant use in chronic kidney disease and dialysis patients with atrial fibrillation. | 2019 | Nephrology Dialysis Transplantation |
| Medication adherence to rivaroxaban and dabigatran in patients with non-valvular atrial fibrillation: A meta-analysis. | 2019 | Journal of Thrombosis and Thrombolysis |
| Venous thromboembolism prophylaxis strategies for people undergoing elective total knee replacement: A systematic review and network meta-analysis. | 2019 | The Lancet Haematology |
| Venous thromboembolism prophylaxis strategies for people undergoing elective total hip replacement: A systematic review and network meta-analysis. | 2019 | Value in Health |
| Safety and efficacy of direct acting oral anticoagulants and vitamin K antagonists in nonvalvular atrial fibrillation – A network meta-analysis of real-world data. | 2019 | VASA |
